Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04347811 · ClinicalTrials.gov registry record · NA

Use of Death Cafes to Prevent Burnout in ICU Healthcare Employees

A NA study of Depression and Anxiety, sponsored by Tulane University School of Medicine.

Completed
Registry status
NA
Development phase
340
Enrollment target
4
Study locations

NCT04347811: Completed NA study of Depression and Anxiety, sponsored by Tulane University School of Medicine.

NCT04347811 is a NA study of Depression and Anxiety that has completed, run by Tulane University School of Medicine. The registered enrollment target is 340 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (57% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04347811, a NA study of Depression and Anxiety, has completed, sponsored by Tulane University School of Medicine.

COMPLETED
Registry status
NA
Development phase
340 participants
Enrollment target
4
Study locations

Study Summary

Burnout affects a significant number of healthcare employees and leads to worsened mental health, increased job turnover, and patient safety events. Those caring for critically ill patients may be especially susceptible due to high patient mortality, long hours, and regular encounters with traumatic and ethical issues. Preliminary studies suggest that debriefing opportunities may reduce burnout through reflection on distressing patient events, enhancement of social support, and interprofessional collaboration. Death Cafés are a specific form of debriefing that focus on discussing death, dying, loss, and illness. The purpose of this study is to evaluate whether biweekly Death Cafe group debriefing sessions can prevent burnout in ICU physicians and staff.

Primary Outcome

This is a validated 22-item, self-reported questionnaire that asks respondents to indicate on a 7 point Likert scale the frequency of certain feelings related to their job. Presence of burnout is defined by high values of depersonalization and emotional exhaustion with low values for personal accomplishment. Changes in mean scores between groups and within groups over time will be assessed.

Interventions

  • BEHAVIORAL Death Cafe

Study Locations (4)

Louisiana

  • Tulane Medical Center - New Orleans
  • University Medical Center - New Orleans
  • Children's Hospital New Orleans - New Orleans
  • Ochsner Medical Center - New Orleans

Trial Details

FieldValue
Enrollment Target 340 participants
Start Date 2020-07-20
Est. Completion 2022-12-26
Phase NA

What the finished NCT04347811 record still lists

NCT04347811 is an interventional study that assigns participants to a tested intervention. The registered 340 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (57% lower).

The record links to 5 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Death Cafe is the first listed.

NCT04347811 reports a single indexed study location in Louisiana.

Frequently Asked Questions

What is clinical trial NCT04347811 about?

NCT04347811 is a clinical study titled "Use of Death Cafes to Prevent Burnout in ICU Healthcare Employees". Burnout affects a significant number of healthcare employees and leads to worsened mental health, increased job turnover, and patient safety events. Those caring for critically ill patients may be especially susceptible due to high patient mortality, long hours, and regular encounters with traumatic...

What is the current status of trial NCT04347811?

This trial is currently completed. It is a NA study. The enrollment target is 340 participants. The study started on 2020-07-20. Estimated completion is 2022-12-26.

What conditions does trial NCT04347811 study?

This clinical trial studies the following conditions: Depression, Anxiety, Burnout, Professional, Burnout, Burnout, Psychological.

What interventions are being tested in trial NCT04347811?

The interventions under investigation include: Death Cafe (BEHAVIORAL).

Who is sponsoring clinical trial NCT04347811?

This trial is sponsored by Tulane University School of Medicine, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04347811 being conducted?

This trial has 4 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04347811's enrollment target sits among peer trials

340 126th of 679 higher than 553 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04176172 · 340 participants · Phase 3

    Optimizing Tobacco Use Treatment for PLWHA

  • NCT04545424 · 340 participants · Phase 2

    Trial of Therapeutic Hypothermia in Patients With ARDS

  • NCT04806958 · 340 participants · NA

    The PulsePoint Study

  • NCT05323409 · 340 participants · NA

    Improving Comprehensive Care of Cancer Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT04347811, the US trial registry maintained by the National Library of Medicine. NCT04347811 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.